Capping is a defect in tablet manufacturing where the top or bottom of the tablet separates from the rest of the tablet.

Insufficient compression force during tablet manufacturing can lead to capping, as the tablet is not adequately compacted.

Weight variation analysis is a quality control procedure used to assess the uniformity of tablet dosage forms by measuring the individual weights of a representative sample of tablets.

The primary objective of conducting a root cause analysis is to identify the underlying cause of a problem in order to prevent its recurrence.

Increasing the compression force is a common corrective action taken to address capping in tablet manufacturing, as it helps to ensure adequate compaction of the tablet.

The primary objective of process validation is to demonstrate that the manufacturing process consistently produces products that meet predetermined quality standards.

Particulate matter contamination, microbial contamination, and pyrogen contamination are all common issues encountered during the manufacturing of sterile injectables.

The purpose of conducting a risk assessment in pharmaceutical manufacturing is to identify potential hazards, assess their risks, develop and implement control measures to mitigate risks, and document risks for future reference.

Weight variation, content uniformity, and dissolution problems are all common issues encountered during the manufacturing of solid oral dosage forms.

The primary objective of quality control in pharmaceutical manufacturing is to ensure that products meet predetermined quality standards.

pH variation, viscosity problems, and microbial contamination are all common issues encountered during the manufacturing of liquid oral dosage forms.

The purpose of conducting stability studies in pharmaceutical manufacturing is to assess the stability of drug products over time, determine the shelf life of drug products, and identify potential degradation pathways.

Skin irritation, allergic reactions, and microbial contamination are all common issues encountered during the manufacturing of topical dosage forms.

The primary objective of good manufacturing practices (GMP) in pharmaceutical manufacturing is to ensure that products are manufactured in a consistent and controlled manner, minimize the risk of contamination and errors, and comply with regulatory requirements.

Particulate matter contamination, microbial contamination, and pyrogen contamination are all common issues encountered during the manufacturing of parenteral dosage forms.